FBXW7 and neoplasm: Based on this evidence, we speculate two mechanisms that contribute to tRF3008A-mediated tumor suppression: the first is the induction of tumor-suppressive tRFs within specific tumor microenvironments, such as hypoxia and tumor mutation burden, and the second is related to upregulated AGO expression, as reported in colorectal cancer [35].